ACAD
ACAD
US0042251084
ACADIA Pharmaceuticals Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.071.505.000 957.797.000
11.9%
Cost of Revenue 88.998.000 81.841.000
8.7%
Gross Profit 982.507.000 875.956.000
12.2%
877.696.000 791.677.000
10.9%
Operating Income 104.811.000 84.279.000
24.4%
Pretax Income 138.904.000 258.075.000
46.2%
Net Income Common Stockholders 391.000.000 226.451.000
72.7%
-- --
--
-- --
--
ende